A population study of clinically actionable genetic variation affecting drug response from the Middle East
<p dir="ltr">Clinical implementation of pharmacogenomics will help in personalizing drug prescriptions and alleviate the personal and financial burden due to inefficacy and adverse reactions to drugs. However, such implementation is lagging in many parts of the world, including the M...
Saved in:
Similar Items
-
Clinically actionable pharmacogenomic landscape of antidepressants and antipsychotics in Qatar: a population-based cohort study
by: Dinesh Velayutham (5444072)
Published: (2025) -
Development and application of an integrated allele-specific pipeline for methylomic and epigenomic analysis (MEA)
by: Julien Richard Albert (655437)
Published: (2018) -
Ratios of Acetaminophen Metabolites Identify New Loci of Pharmacogenetic Relevance in a Genome-Wide Association Study
by: Gaurav Thareja (459188)
Published: (2022) -
Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
by: Kholoud Bastaki (18434094)
Published: (2021) -
Identification of PCSK9-like human gene knockouts using metabolomics, proteomics, and whole-genome sequencing in a consanguineous population
by: Aziz Belkadi (779313)
Published: (2023)